10th Mar 2026 14:27
/**//**//**//**/p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}div.ar{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;margin-left:22.5pt;margin-right:22.5pt}p.ao{text-align:center}span.ap{font-size: 11.0pt;font-family:"Verdana","sans-serif"}div.al{margin-top:7.5pt;margin-bottom:7.5pt}p.as{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";background:#7C173A}span.an{font-size:11.0pt;font-family:"Verdana","sans-serif"}div.aj{margin-left:7.5pt}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";}span.ak{font-size:11.0pt;font-family: "Verdana","sans-serif"}div.ai{border:solid #666666 1.0pt;padding:0cm 0cm 0cm 0cm;margin-left: 9.75pt;margin-top:3.75pt;margin-bottom:7.5pt}div.ah{margin-left:1.5pt}div.ag{border:solid #666666 1.0pt;padding:0cm 0cm 0cm 0cm;margin-left: 1.5pt;margin-top:3.75pt;margin-bottom:7.5pt}table.at{width:406.15pt;margin-left:-.75pt;border-collapse:collapse;border:none}td.ae{border-top:solid #666666 1.0pt;border-left:solid #666666 1.0pt; border-bottom:none;border-right:none;padding:.75pt .75pt .75pt .75pt}p.au{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:center}span.af{color:white}td.ac{border:solid #666666 1.0pt;padding:.75pt .75pt .75pt 6.0pt}span.ad{font-size:7.5pt;font-family: "Verdana","sans-serif"}td.ab{border:solid #666666 1.0pt;border-left:none; padding:.75pt .75pt .75pt 6.0pt}td.y{border:solid #666666 1.0pt;padding:.75pt .75pt .75pt .75pt}p.av{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:3.75pt;margin-right:0cm;margin-bottom: 7.5pt;margin-left:9.75pt}span.aa{font-size:11.0pt; font-family:"Verdana","sans-serif"}td.x{border-top:none;border-left:none;border-bottom:solid #666666 1.0pt; border-right:solid #666666 1.0pt;padding:.75pt .75pt .75pt .75pt}td.w{border:solid #666666 1.0pt;border-top:none;padding:.75pt .75pt .75pt .75pt}table.aw{width:406.15pt;margin-left:-1.5pt;border-collapse:collapse;border:none}td.u{width:20.0%;border:solid #666666 1.0pt;padding:.75pt .75pt .75pt 1.5pt}td.t{border:solid #666666 1.0pt;border-left:none; padding:.75pt .75pt .75pt 1.5pt}td.q{width:20.0%;border:solid #666666 1.0pt;border-top: none;padding:.75pt .75pt .75pt .75pt}p.ax{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:3.75pt;margin-right:0cm;margin-bottom: 7.5pt;margin-left:2.25pt}span.s{font-size:10.0pt; font-family:"Verdana","sans-serif"}td.o{border:solid #666666 1.0pt;border-top:none; padding:.75pt .75pt .75pt 1.5pt}span.p{font-size:7.5pt;font-family:"Verdana","sans-serif"}td.n{border-top:none;border-left:none;border-bottom:solid #666666 1.0pt; border-right:solid #666666 1.0pt;padding:.75pt .75pt .75pt .75pt}span.l{font-size:10.0pt}p.ay{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:3.75pt;margin-right:0cm; margin-bottom:7.5pt;margin-left:9.75pt;text-align:center}td.j{width:15.0%;border:solid #666666 1.0pt;padding:.75pt .75pt .75pt 1.5pt}td.i{width:15.0%;border:solid #666666 1.0pt;border-top: none;padding:.75pt .75pt .75pt .75pt} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .WordSection1_tidyNotWord-35{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;}/**//**//**//**/ RNS Number : 0954W Advanced Medical Solutions Grp PLC 10 March 2026 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0004536594 Issuer Name ADVANCED MEDICAL SOLUTIONS GROUP PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Octopus Investments Limited City of registered office (if applicable) London Country of registered office (if applicable) England 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office (if applicable) Country of registered office (if applicable) 5. Date on which the threshold was crossed or reached 03-Mar-2026 6. Date on which Issuer notified 04-Mar-2026 7. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer Resulting situation on the date on which threshold was crossed or reached 9.980000 0.000000 9.980000 21922329 Position of previous notification (if applicable) 10.990000 0.000000 10.990000 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1) GB0004536594 21922329 9.980000 Sub Total 8.A 21922329 9.980000% 8B1. Financial Instruments according to (DTR5.3.1R.(1) (a)) Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights Sub Total 8.B1 8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b)) Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights Sub Total 8.B2 9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary) Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold Octopus Capital Limited Octopus Investments Limited 9.980000 9.980000% 10. In case of proxy voting Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional Information 12. Date of Completion 04/03/2026 13. Place Of Completion 33 Holborn, London, EC1N 2HT This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END HOLURUSRNVUOAAR